Beneficio Operativo Cambio Fecha
Alterity Therapeutics Limited AUD -8.07M 302.4K 2025-12
Ardelyx USD -12.42M 20.37M 2026-06
aTyr Pharma USD -104K 24K 2026-06
Biogen USD 419.5M 663.3M 2026-09
Bristol-Myers Squibb USD 255M 44M 2026-09
Cipla INR 10.43B 1.55B 2026-09
Clal Biotechnology ILS -1.74M 7.46M 2022-12
Compugen USD -8.84M 180K 2026-06
CSL USD 2.64B 1.97B 2025-12
Curis USD -11.52M 3.64M 2026-03
GlaxoSmithKline GBP 2.86B 251M 2026-09
Grifols EUR 320.55M 91.01M 2025-12
Lakefront Biotherapeutics EUR -41.17M 2.34M 2026-09
Novartis USD 5.14B 392M 2026-09
Roche Holding CHF 11.46B 1.91B 2026-06
United Therapeutics USD 241.3M 89.5M 2026-09